As shown in Figure 1B , 5 mg/kg of IV LPS produced a trend toward decreased lung catalase activity compared to control, though this difference did not reach statistical significance (0.055 vs. 0.18, P = 0.05).
← all excerpts
The tyrosine kinase inhibitor imatinib prevents lung injury and death after intravenous LPS in mice.
1
0.0500
0.0500